XOM
42
-6
WM
74
-5
REGN
38
-2
YUM
43
-6
ADBE
47
-9
AIV
64
4
HPE
44
-2
SWKS
38
-2
IR
63
-3
WYNN
36
-5
EQR
54
3
MRK
17
-5
EOG
56
-2
WBA
43
-4
CMS
60
2
HCA
48
-2
COST
57
-6
AN
50
-5
PLD
45
-5
CNX
73
-3
XOM
42
-6
WM
74
-5
REGN
38
-2
YUM
43
-6
ADBE
47
-9
AIV
64
4
HPE
44
-2
SWKS
38
-2
IR
63
-3
WYNN
36
-5
EQR
54
3
MRK
17
-5
EOG
56
-2
WBA
43
-4
CMS
60
2
HCA
48
-2
COST
57
-6
AN
50
-5
PLD
45
-5
CNX
73
-3
Financhill
Back

PIMCO Income Strategy Fund II Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
44

PFN
PIMCO Income Strategy Fund II

Last Price:
7.42
Seasonality Move:
0.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
44
PIMCO Income Strategy Fund II (PFN) is a Sell

Is PIMCO Income Strategy Fund II a Buy, Sell or Hold?

  • The current PIMCO Income Strategy Fund II [PFN] share price is $7.41. The Score for PFN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PFN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PFN Stock Price Chart

What is PIMCO Income Strategy Fund II's stock price today?

  • The PIMCO Income Strategy Fund II share price today is $7.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFN is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PFN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 33.57 Sell
Chaikin Money Flow: 298708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.47 - 7.57) Sell
Bollinger Bands (100): (7.2 - 7.56) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PFN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.5 Sell
20-day SMA: 7.51 Sell
50-day SMA: 7.54 Sell
200-day SMA: 7.37 Buy
8-day EMA: 7.47 Sell
20-day EMA: 7.51 Sell
50-day EMA: 7.5 Sell
200-day EMA: 7.36 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

PIMCO Income Strategy Fund II Earnings Growth & PFN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

PIMCO Income Strategy Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):